regarding elevation of lab parameters [GxP / QC / QA]

posted by Varsha – 2014-09-01 16:36 (3523 d 16:36 ago) – Posting: # 13447
Views: 4,893

Dear all,

We have conducted one BA BE study where at the time of screening, the volunteers were having normal ESR values but the post study safety reports after the drug administration reveals increase clinically significant ESR values and were considered as adverse event for nearly 18 subjects out of 48 subjects. The physician has documented the AE as not related to the drug as there is not linerature evidence for the same.

My concern is, is the documentation correct? What may be the reason for increase of ESR values for all these subjects.
Regards,
Varsha

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
108 visitors (0 registered, 108 guests [including 2 identified bots]).
Forum time: 09:12 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5